[European Union] Regulatory Insights on Medical Devices and DLT Innovation

This episode delivers comprehensive updates on regulatory developments across critical sectors including Medical Device safety, Distributed Ledger Technology (DLT), the National Emissions Trading System (nEHS), Ankle Replacement device risks, and Consumer Duty mandates.Listeners will gain insights into the UK Financial Conduct Authority’s recent restrictions on Kingscrown Finance Limited and the opening of pre-application meetings for cryptoasset firms. In Germany, the expansion of the national emissions trading system now includes waste incineration emissions, increasing compliance requirements for obligated entities.Additionally, the episode highlights the Central Bank of Ireland’s progressive approach to tokenised finance, enabling DLT assets as collateral and supporting digital euro development. The urgent field safety notice for the Remisol Advance device underscores ongoing vigilance in medical device monitoring. These updates inform stakeholders on evolving regulatory landscapes and risk management practices.For more information, visit the Carver Agents website.Articles mentioned:News storiesUrgent Field Safety Notice for Remisol Advance by NORMAND INFOnEHS: Emissionssituation 2024UPDATE: Hintermann Series H3 Total Ankle Replacement Has a Higher-Than-Expected Risk of Device Failure: FDA Safety CommunicationStatementsInformation and communication technology (ICT) risk management: range of practicesFSB Plenary highlights potential new vulnerabilities to financial stability01.06.2026 - Place du coefficient de saturation de la transferrine pour le diagnostic de carence martialePublication - 07.07.2026 - Financial Stability Report - July 2026 (to be published at 10.30am)Vasileios Madouros: Finance in transition - the Central Bank of Ireland's approach to tokenised finance